Your browser doesn't support javascript.
loading
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Garcia-Beltran, Wilfredo F; St Denis, Kerri J; Hoelzemer, Angelique; Lam, Evan C; Nitido, Adam D; Sheehan, Maegan L; Berrios, Cristhian; Ofoman, Onosereme; Chang, Christina C; Hauser, Blake M; Feldman, Jared; Roederer, Alex L; Gregory, David J; Poznansky, Mark C; Schmidt, Aaron G; Iafrate, A John; Naranbhai, Vivek; Balazs, Alejandro B.
Affiliation
  • Garcia-Beltran WF; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: wgarciabeltran@mgh.harvard.edu.
  • St Denis KJ; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Hoelzemer A; First Department of Internal Medicine, Division of Infectious Diseases, University Medical Centre Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Site Hamburg-Lübeck-Borstel-Riems, Germany; Research Department Virus Immunology, Leibniz Institute for Experimental Virology, H
  • Lam EC; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Nitido AD; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
  • Sheehan ML; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Berrios C; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Ofoman O; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Chang CC; Alfred Hospital, Central Clinical School, Monash University, Victoria 3181, Australia; Center for the AIDS Programme of Research in South Africa, Durban 4001, South Africa.
  • Hauser BM; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Feldman J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
  • Roederer AL; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
  • Gregory DJ; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA 02129, USA; Pediatric Infectious Disease, Massachusetts General Hospital for Children, Boston, MA 02114, USA.
  • Poznansky MC; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA 02129, USA; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
  • Schmidt AG; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Naranbhai V; Center for the AIDS Programme of Research in South Africa, Durban 4001, South Africa; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Balazs AB; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: abalazs@mgh.harvard.edu.
Cell ; 185(3): 457-466.e4, 2022 02 03.
Article in En | MEDLINE | ID: mdl-34995482
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Year: 2022 Document type: Article Country of publication: Estados Unidos